Torrent Pharmaceuticals Ltd. Financials: Quarterly Results
Revenue
3219
Cr.
PAT
591
Cr.
EBITDA
852
Cr.
Torrent Pharmaceuticals Ltd. Q2FY26 Financial Metrics
| Indicator | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 3246 | 3128 | 2909 | 2809 | 2889 |
| Total Income From Operations (Cr.) | 3302 | 3178 | 2959 | 2809 | 2889 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 852 | 794 | 745 | 748 | 725 |
| P/L Before Exceptional Items & Tax (Cr.) | 804 | 738 | 689 | 691 | 661 |
| P/L After Tax from Ordinary Activities (Cr.) | 591 | 548 | 498 | 503 | 453 |
| Net Profit/Loss For the Period (Cr.) | 591 | 548 | 498 | 503 | 453 |
| Basic EPS | 17.45 | 16.19 | 14.71 | 14.88 | 13.37 |
FAQs
Torrent Pharmaceuticals Ltd. announced its quarterly results for Q2 FY2026 on November 7, 2025.
In Q2 FY2026, Torrent Pharmaceuticals Ltd. are as follows:
Revenue: ₹3219 crore
Net Profit: ₹591 crore.
For Q2 FY2026, Torrent Pharmaceuticals Ltd. posted ₹3219 crore in revenue and ₹591 crore in net profit.
Past quarterly results for Torrent Pharmaceuticals Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.